156 related articles for article (PubMed ID: 30590007)
21. The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
Seemanova E; Varon R; Vejvalka J; Jarolim P; Seeman P; Chrzanowska KH; Digweed M; Resnick I; Kremensky I; Saar K; Hoffmann K; Dutrannoy V; Karbasiyan M; Ghani M; Barić I; Tekin M; Kovacs P; Krawczak M; Reis A; Sperling K; Nothnagel M
PLoS One; 2016; 11(12):e0167984. PubMed ID: 27936167
[TBL] [Abstract][Full Text] [Related]
22. Epidemiologic, clinical, and molecular characteristics of hereditary prostate cancer in Latvia.
Abele A; Vjaters E; Irmejs A; Trofimovičs G; Miklaševičs E; Gardovskis J
Medicina (Kaunas); 2011; 47(10):579-85. PubMed ID: 22186123
[TBL] [Abstract][Full Text] [Related]
23. Current evidence on the relationship between two polymorphisms in the NBS1 gene and breast cancer risk: a meta-analysis.
Zhang ZH; Yang LS; Huang F; Hao JH; Su PY; Sun YH
Asian Pac J Cancer Prev; 2012; 13(11):5375-9. PubMed ID: 23317186
[TBL] [Abstract][Full Text] [Related]
24. Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women.
Mateju M; Kleiblova P; Kleibl Z; Janatova M; Soukupova J; Ticha I; Novotny J; Pohlreich P
Breast Cancer Res Treat; 2012 Jun; 133(2):809-11. PubMed ID: 22491912
[No Abstract] [Full Text] [Related]
25. Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer.
Zuhlke KA; Johnson AM; Okoth LA; Stoffel EM; Robbins CM; Tembe WA; Salinas CA; Zheng SL; Xu J; Carpten JD; Lange EM; Isaacs WB; Cooney KA
Fam Cancer; 2012 Dec; 11(4):595-600. PubMed ID: 22864661
[TBL] [Abstract][Full Text] [Related]
26. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
Nowak J; Mosor M; Ziółkowska I; Wierzbicka M; Pernak-Schwarz M; Przyborska M; Roznowski K; Pławski A; Słomski R; Januszkiewicz D
Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
[TBL] [Abstract][Full Text] [Related]
27. A personalised approach to prostate cancer screening based on genotyping of risk founder alleles.
Cybulski C; Wokołorczyk D; Kluźniak W; Kashyap A; Gołąb A; Słojewski M; Sikorski A; Puszyński M; Soczawa M; Borkowski T; Borkowski A; Antczak A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Domagała P; Piotrowski K; Menkiszak J; Krzystolik K; Gronwald J; Jakubowska A; Górski B; Dębniak T; Masojć B; Huzarski T; Muir KR; Lophatananon A; Lubiński J; Narod SA;
Br J Cancer; 2013 Jun; 108(12):2601-9. PubMed ID: 23722471
[TBL] [Abstract][Full Text] [Related]
28. Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?
Lener MR; Scott RJ; Kluźniak W; Baszuk P; Cybulski C; Wiechowska-Kozłowska A; Huzarski T; Byrski T; Kładny J; Pietrzak S; Soluch A; Jakubowska A; Lubiński J
Int J Cancer; 2016 Aug; 139(3):601-6. PubMed ID: 27038244
[TBL] [Abstract][Full Text] [Related]
29. Germline 657del5 mutation in the NBS1 gene in breast cancer patients.
Górski B; Debniak T; Masojć B; Mierzejewski M; Medrek K; Cybulski C; Jakubowska A; Kurzawski G; Chosia M; Scott R; Lubiński J
Int J Cancer; 2003 Sep; 106(3):379-81. PubMed ID: 12845677
[TBL] [Abstract][Full Text] [Related]
30. Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk.
Zhang G; Zeng Y; Liu Z; Wei W
Tumour Biol; 2013 Oct; 34(5):2753-7. PubMed ID: 23765759
[TBL] [Abstract][Full Text] [Related]
31. Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation.
Cilli D; Mirasole C; Pennisi R; Pallotta V; D'Alessandro A; Antoccia A; Zolla L; Ascenzi P; di Masi A
PLoS One; 2014; 9(12):e114651. PubMed ID: 25485873
[TBL] [Abstract][Full Text] [Related]
32. Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions.
Dzikiewicz-Krawczyk A; Mosor M; Januszkiewicz D; Nowak J
Mutagenesis; 2012 May; 27(3):337-43. PubMed ID: 22131123
[TBL] [Abstract][Full Text] [Related]
33. Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin.
Debniak T; Górski B; Cybulski C; Jakubowska A; Kurzawski G; Lener M; Mierzejewski M; Masojć B; Medrek K; Kładny J; Załuga E; Maleszka R; Chosia M; Lubiński J
Melanoma Res; 2003 Aug; 13(4):365-70. PubMed ID: 12883362
[TBL] [Abstract][Full Text] [Related]
34. Is the NBN gene mutation I171V a potential risk factor for malignant solid tumors in children?
Nowak J; Mosor M; Nowicka K; Rembowska J; Januszkiewicz D
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e248-9. PubMed ID: 21436738
[TBL] [Abstract][Full Text] [Related]
35. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
[TBL] [Abstract][Full Text] [Related]
36. Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.
Leongamornlert DA; Saunders EJ; Wakerell S; Whitmore I; Dadaev T; Cieza-Borrella C; Benafif S; Brook MN; Donovan JL; Hamdy FC; Neal DE; Muir K; Govindasami K; Conti DV; Kote-Jarai Z; Eeles RA
Eur Urol; 2019 Sep; 76(3):329-337. PubMed ID: 30777372
[TBL] [Abstract][Full Text] [Related]
37. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin.
Thirumaran RK; Bermejo JL; Rudnai P; Gurzau E; Koppova K; Goessler W; Vahter M; Leonardi GS; Clemens F; Fletcher T; Hemminki K; Kumar R
Carcinogenesis; 2006 Aug; 27(8):1676-81. PubMed ID: 16501254
[TBL] [Abstract][Full Text] [Related]
38. PALB2 mutations and prostate cancer risk and survival.
Wokołorczyk D; Kluźniak W; Stempa K; Rusak B; Huzarski T; Gronwald J; Gliniewicz K; Kashyap A; Morawska S; Dębniak T; Jakubowska A; Szwiec M; Domagała P; Lubiński J; Narod SA; Akbari MR; Cybulski C;
Br J Cancer; 2021 Aug; 125(4):569-575. PubMed ID: 34006922
[TBL] [Abstract][Full Text] [Related]
39. BRCA1 mutations and prostate cancer in Poland.
Cybulski C; Górski B; Gronwald J; Huzarski T; Byrski T; Debniak T; Jakubowska A; Wokołorczyk D; Gliniewicz B; Sikorski A; Stawicka M; Godlewski D; Kwias Z; Antczak A; Krajka K; Lauer W; Sosnowski M; Sikorska-Radek P; Bar K; Klijer R; Romuald Z; Małkiewicz B; Borkowski A; Borkowski T; Szwiec M; Posmyk M; Narod SA; Lubiński J
Eur J Cancer Prev; 2008 Feb; 17(1):62-6. PubMed ID: 18090912
[TBL] [Abstract][Full Text] [Related]
40. Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.
Escherich CS; Chen W; Li Y; Yang W; Nishii R; Li Z; Raetz EA; Devidas M; Wu G; Nichols KE; Inaba H; Pui CH; Jeha S; Camitta BM; Larsen E; Hunger SP; Loh ML; Yang JJ
Blood; 2024 May; 143(22):2270-2283. PubMed ID: 38446568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
